ATRA-ND was shown to enhance apoptosis and cell-cycle arrest in MCL cell lines, resulting in increased p21, p27, and p53 expression and decreased cyclin D1 expression; these results suggest that ATRA-ND may represent a potentially effective approach to the treatment of MCL. Here, CCND1 is linked to mantle cell lymphoma.